TG Therapeutics Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Buy

TGTX
TG Therapeutics

Last Price:

$33.67

Seasonality Move:

-2.26%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

TG Therapeutics Stock Forecast

Over the next 52 weeks, TG Therapeutics has on average historically risen by 20.6% based on the past 28 years of stock performance.
TG Therapeutics has risen higher in 11 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.29%
Is TG Therapeutics Stock Undervalued?

The current TG Therapeutics [TGTX] share price is $33.64. The Score for TGTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
TGTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, TG Therapeutics has on average historically risen by 20.6% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Buy

TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

TG Therapeutics has risen higher in 11 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.29%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

tgtherapeutics.com

52-Week Data

52-Week High:

46.48

52-Week Low:

15.16

Prediction Charts

Market Cap:

5.3B

Price in USD:

33.64

Volume:

2.2M

Beta:

0.94

Technical Analysis

SMA50:

38.50

SMA100:

34.80

SMA200:

29.89

52-Wk Change:

98.82%

Stock Predictions

Is TG Therapeutics stock public?

Yes, TG Therapeutics is a publicly traded company.
What is the TG Therapeutics stock quote today?

The TG Therapeutics stock price is 33.64 USD today.
How to buy TG Therapeutics stock online?

You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	37.62	37.99	38.58	37.48
Apr-23	38.75	39.49	40.35	38.47
Apr-24	39.50	40.30	41.08	39.41
Apr-25	40.04	41.33	41.37	39.51
Apr-28	41.82	42.03	42.46	40.95
Apr-29	42.18	43.86	43.98	41.64
Apr-30	42.87	45.47	45.83	42.76
May-1	45.49	45.37	46.48	44.05
May-2	45.37	43.44	45.97	42.96
May-5	39.76	37.68	40.48	35.62
May-6	37.27	34.86	37.27	34.03
May-7	34.94	34.85	35.47	34.22
May-8	34.18	33.86	35.14	33.15
May-9	33.80	33.64	34.73	33.45

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.18 per share, an increase this year of $0.77 per share, and an increase next year of $0.85 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.